Sporadic Hepatitis C virus infection: A case-control study of transmission routes in a selected hospital sample of the general population in Italy

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 1, 1998, Pages 11-15

  Visco Comandini, Ubaldo ^b,c   Tossini, Gianna ^a   Longo, Maria Antonella ^a   Ferri, Fabrizio ^a   Cuzzi, Gilda ^a   Noto, Pasquale ^a   Zaccarelli, Mauro ^a   Visco, Giuseppe ^a,c  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS C ANTIBODY;

ADULT; AGE; AGED; ARTICLE; BLOOD TRANSFUSION; CASE CONTROL STUDY; CONTROLLED STUDY; DELIVERY; DENTAL CARE; DIABETES MELLITUS; FAMILY; FEMALE; GENDER; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTRAVENOUS ADMINISTRATION; INTRAVENOUS DRUG ABUSE; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEEDLE; OCCUPATION; QUESTIONNAIRE; RISK FACTOR; SERODIAGNOSIS; SEROPREVALENCE; SURGICAL PATIENT; VIRUS TRANSMISSION;

EID: 7144242312     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655498750002231     Document Type: Article

References (32)

1. Mattsson L, Grillner L, Weiland O. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test. Scand J Infect Dis 1992; 24: 15-20.
2. van den Hoek JA, van Haastrecht HJ. Goudsmit J, de Volf F, Coutinho RA. Prevalence, incidence and risk factors in Hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990; 162; 823-6.
3. Mele A, Sagliocca L, Manzillo G, Converti F, Amoroso P, Stazi MA, Ferrigno L, Rapicetta M, Franco E, Adamo B. Risk factors for acute non-A, non-B hepatitis and their relationship to antibodies for hepatitis C virus: a case-control study. Am J Public Health 1994; 84: 1640-3.
4. Cendoroglo Neto M, Draibe SA, Silva AE, Ferraz ML, Granato C, Pereira CA, Sesso RC, Gaspar AM, Ajzen H. Incidence of the risk factors for hepatitis B virus and hepatitis C virus infection among haemodiaysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995; 10: 240-6.
5. Janot C, Courouce AM, Maniez M. Antibodies to hepatitis C virus in French blood donors. Lancet 1989; 2: 796-7.
6. Sirchia G, Bellobuono A, Giovanetti A, Marconi M. Antibodies to HCV in Italian blood donors. Lancet 1989; 2: 797.
7. Merino-Conde E, Orozco JA, Rojo-Medina J, Tovar A. Prevalence of hepatitis C virus among candidates for blood donation. In Vivo 1994; 8: 621-3.
8. Campello C, Majori S, Poli A, Pacini P, Nicolardi L, Pini F. Prevalence of HCV antibodies in health-care workers from northern Italy. Infection 1992; 20: 224-46.
9. Mele A, Corona R, Tosti ME, Palumbo F, Moiraghi A, Novaco F, Galanti C, Bernacchia R, Ferraro P. Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy. Scand J Infect Dis 1995; 27: 441-4.
10. Mele A, Stroffolini T, Pasquini P. SEIEVA integrated Epidemiological System for Acute Viral Hepatitis 1985-1994. Rapporti ISTISAN 1996; 3: 1-10.
11. Fischler B, Lindh G, Lindgren S, Forsgren M, Vonsydow M, Sangfelt P. et al. Vertical transmission of Hepatitis C virus infection. Scand J Inject Dis 1996; 28: 353-6.
12. Marino N, Di Pietro M, Moschitta P, Balocchini E, Chionne P, Spada E, Rapicetta M, Stroffolini T, Mazzotta F. Intrafamily spread of hepatitis C virus infection. New Microbiologia 1994; 17: 147-50.
13. Stroffolini T, Menichelli M, Taliani G, Dambruoso V, Poliandri G, Bozza A, et al. High prevalence of hepatitis C virus infection in a small central Italian town: lack of evidence of parenteral exposure. Ital J Gastroenterol 1995; 27: 235-8.
14. Visco G, Longo MA, Noto P, Tossini G, Ferri F, Zaccarelli M, Visco Comandini U. Attualità sull 'epidemiologia dell' epatite da HCV [Italian]. Oplitai 1994; 7: 37-40.
15. D'Amelio R, Stroffolini T, Matricardi PM, Nisini R, Tosti ME, Trematerra M, et al. Low prevalence of anti-HCV antibodies among Italian Air Force recruits. Scand J Infect Dis 1995; 27: 12-4.
16. Gaeta GB, Giusti G. Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends. Infection 1990; 18: 21-5.
17. Quan CM, Krajden M, Grigoriew GA. Salit IE. Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clin Infect Dis 1993; 17: 117-9.
18. David XR, Blanc P, Pageaux GP, Desprez D, Diaz D, Lemaire JM, et al. Familial transmission of hepatitis C virus [French]. Gastroenterol Clin Biol 1995; 19: 150-5.
19. Manzini P, Saracco G, Cerchier A, Riva C, Musso A, Ricotti E, et al. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology 1995; 21: 328-32.
20. Chang TT, Liou TC, Young KC, Lin XZ, Lin CY, Shin JS, Wu HL. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol 1994; 42: 91-6.
21. Porter S, Scully C, Samaranayake L. Viral hepatitis. Current concepts for dental practice. Oral Surg Oral Med Oral Pathol 1994; 78: 682-95.
22. Sodeyama T, Kiyosawa K, Urushihara A, Matsumoto A, Tanaka E, Furuta S, Akahane Y. Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents. Arch Intern Med 1993; 153: 1565-72.
23. Struve J, Aronsson B, Frenning B, Forsgren M, Weiland O. Prevalence of antibodies against hepatitis C virus infection among health care workers in Stockholm. Scand J Gastroenterol 1994; 29: 360-2.
24. Melbye M, Biggar RJ, Wantzin P, Krogsgaard K, Ebbesen P, Becker NG. Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men. BMJ 1990; 301: 210-2.
25. Nakashima, Ikematsu H, Hayashi J, Kishihara Y, Mutsutake A, Kashiwagi S. Intrafamilial transmission of hepatitis-C virus among the population of an endemic area of Japan. JAMA 1995; 274: 1459-1461.
26. Pohjanpelto P. Risk factors connected with hepatitis C infections in Finland. Scand J Infect Dis 1992; 24: 251-2.
27. Healey CJ, Smith DB, Walker JL, Holmes EC, Fleming KA, Chapman RW, Simmonds P. Acute hepatitis C infection after sexual exposure. Gut 1995; 36: 148-50.
28. Visco G, Longo MA, Noto P, Tossini G. Ferri F, Zaccarelli M, Visco Comandini U. First demonstration of the main transmission routes for HCV infection in Italy: prevalence of some risk factors in a selected population sample in Rome [Abstract no. 414]. 6th Congress International Society of Infectious Diseases, Prague, Czech Republic. 1994.
29. Chiaramonte M, Stroffolini T, Lorenzoni U, Minniti F, Conti S, Floreani A, et al. Risk factors in community-acquired chronic Hepatitis C virus infection - a case-control study in Italy. J Hepatol 1996; 24: 129-34.
30. Romanó L, Azara A, Chiaramonte M, De Mattia D, Giammanco A, Moschen ME, et al. Low prevalence of HCV antibody among Italian children. Infection 1994; 22: 350-2.
31. Morfini M, Mannucci PM, Ciavarella N, Schiavoni M, Gringeri A, Rafanelli D, et al. Prevalence of infection with the hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates: a retrospective evaluation. Vox Sang 1994; 178-182.
32. Schulman S, Lindgren AC, Petrini P, Allander T. Transmission of hepatitis C with pasteurised factor VIII [Letter]. Lancet 1992; 340: 305-6.